SCHEMBL7419283

SCHEMBL7419283

CCCc1c(C(=O)C(C)C)c2cc(C(=O)OC)ccc2n1Cc1cc2c(cc1Cl)OCO2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
RXFP1 Q9HBX9 1/20 0.37
HPGD P15428 1/20 0.37
EDNRA P25101 4/20 0.36
SLC22A12 Q96S37 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
EDNRB P24530 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7425503 0.90 EDNRA (0.41) MAPK1HPGDEDNRASLC22A12EDNRB
SCHEMBL7427422 0.90 NPC1 (0.37) SMN1; SMN2LMNAMAPTMEN1KMT2A
SCHEMBL7425289 0.85 L3MBTL1 (0.44) LMNAMAPTGAAMAPK1MEN1
SCHEMBL7423537 0.84 MEN1 (0.40) SMN1; SMN2LMNAMAPTGAAHSD17B10
SCHEMBL7429126 0.82 MEN1 (0.40) SMN1; SMN2LMNAMAPTGAAHSD17B10
SCHEMBL7423832 0.81 SLC22A12 (0.46) SMN1; SMN2LMNAMAPTGAAHSD17B10
SCHEMBL7421260 0.79 S1PR3 (0.40) SMN1; SMN2LMNAMAPTGAAMAPK1
SCHEMBL7424721 0.78 SLC22A12 (0.57) SMN1; SMN2HSD17B10TSHRHPGDEDNRA
SCHEMBL7427199 0.78 SLC22A12 (0.47) SMN1; SMN2LMNAMAPTTSHRMAPK1
SCHEMBL7425401 0.78 MAPT (0.43) LMNAMAPTTSHRMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed